Healthcare / Medical Care FacilitiesThailand
$18.70
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $378.0M · quality 45.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3.0B
P/E
19.3x
↓EV/EBITDA
7.6x
↓ROE
6.8%
↑Gross Margin
20.1%
↓Debt/Equity
2.93
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.7%
FCF CAGR
+35.5%
FCF margin
16.2%
FCF / Net income
6.91x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $6.53B · net income $152.8M · FCF $1.06B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.53B | $6.53B | $6.63B | $6.63B | $6.03B |
| Net Income | $152.8M | $152.8M | $71.8M | $288.9M | $385.3M |
| EBITDA | $1.21B | $1.21B | $1.19B | $1.46B | $1.38B |
| EPS | 0.95 | 0.95 | 0.45 | 1.81 | 2.41 |
| Gross Margin | 20.1% | 20.1% | 19.6% | 23.5% | 23.0% |
| Operating Margin | 7.1% | 7.1% | 5.7% | 10.6% | 10.7% |
| Net Margin | 2.3% | 2.3% | 1.1% | 4.4% | 6.4% |
| Balance Sheet | |||||
| Debt/Equity | 2.93 | 2.93 | 3.30 | 3.33 | 3.34 |
| Current Ratio | 0.50 | 0.50 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $1.06B | $1.06B | $378.0M | $179.1M | $424.2M |
| Returns | |||||
| ROE | 6.8% | 6.8% | 3.2% | 13.0% | 17.4% |
| Valuation | |||||
| P/E | 19.28 | 19.28 | 59.44 | 45.09 | 12.90 |
| EV/EBITDA | 7.57 | 7.57 | 9.63 | 13.82 | 8.79 |
| P/B | 1.34 | 1.34 | 1.92 | 5.85 | 2.25 |
| Growth & Yield | |||||
| Revenue Growth | -1.6% | -1.6% | -0.0% | 9.9% | — |
| EPS Growth | 111.1% | 111.1% | -75.1% | -24.9% | — |
| Dividend Yield | 2.2% | 2.2% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
20.4%
EPS terminal req.
$1.66
Spread vs growth
90.7%
5Y implied EPS CAGR
16.1%
EPS terminal req.
$2.01
Spread vs growth
95.0%
10Y implied EPS CAGR
13.0%
EPS terminal req.
$3.23
Spread vs growth
98.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-12.5%
Start / end P/E
46.9x → 18.9x
EPS bridge
0.45 → 0.95
Residual
-66.2%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.